Company Filing History:
2 out of 2,405 
1 out of 55 Years Active: 2018-2021
Title: The Innovations of Irina Kazakevich: A Pioneer in Pharmaceutical Patents
Introduction: Irina Kazakevich is an accomplished inventor based in Rockaway, NJ, known for her significant contributions to the field of pharmaceuticals. With two patents to her name, her work focuses on innovative formulations that address critical health issues, particularly in the treatment and prevention of HIV and Alzheimer’s disease.
Latest Patents: Irina's latest patents showcase her expertise in pharmaceutical formulations. The first patent, titled "Formulation for parenteral administration," provides a groundbreaking long-acting injectable drug product comprising a suspension of doravirine. This formulation is intended for parenteral administration via intramuscular or subcutaneous routes and is designed for the treatment or prophylaxis of HIV infection, as well as for managing AIDS and AIDS-related complex.
The second patent, "Crystalline forms of a BACE inhibitor, compositions, and their use," offers a novel method for synthesizing verubecestat, alongside two new crystalline forms of the compound. This invention aims to provide valuable therapies for conditions associated with Aβ pathology, including Alzheimer’s disease.
Career Highlights: Irina has held significant positions at noteworthy companies such as Merck Sharp & Dohme Corporation and Merck Sharp & Dohme B.V. Her work has not only involved developing innovative drug formulations but also contributed to advancements in pharmaceutical research and development.
Collaborations: Throughout her career, Irina has collaborated with talented professionals in the industry, including Scott Trzaska and Tao Feng. These collaborations have enhanced her research and contributed to successful patent applications, further establishing her presence in the competitive pharmaceutical landscape.
Conclusion: Irina Kazakevich stands out as a prominent inventor whose work has the potential to transform treatment protocols for both HIV and Alzheimer’s disease. Her innovative spirit and dedication to pharmaceutical advancements continue to inspire and pave the way for future breakthroughs in health care.